Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.020
0.00 (0.00%)
Nov 6, 2026, 12:57 PM CET
Arterra Bioscience Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20 | 20 | 13 | 11 | 14 | 19 | |
Market Cap Growth | -0.66% | 54.08% | 18.07% | -23.15% | -24.57% | 1.75% |
Enterprise Value | 19 | 17 | 10 | 6 | 9 | 15 |
Last Close Price | 3.02 | 2.87 | 1.76 | 1.42 | 1.77 | 2.32 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.09 | 10.02 | 9.76 | 10.27 | 10.17 | 17.17 |
PS Ratio | 3.87 | 4.27 | 3.13 | 3.31 | 4.01 | 4.02 |
PB Ratio | 1.63 | 1.60 | 1.14 | 1.03 | 1.37 | 2.01 |
P/TBV Ratio | 1.63 | 1.60 | 1.15 | 1.03 | 1.38 | 2.04 |
P/FCF Ratio | 16.72 | 13.07 | 30.81 | 11.52 | 11.06 | 22.28 |
P/OCF Ratio | 12.06 | 10.09 | 12.26 | 10.77 | 10.31 | 13.65 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.66 | 3.61 | 2.39 | 1.67 | 2.64 | 3.20 |
EV/EBITDA Ratio | 8.57 | 7.64 | 5.82 | 3.50 | 4.44 | 8.74 |
EV/EBIT Ratio | 9.97 | 8.79 | 7.26 | 5.26 | 5.91 | 12.16 |
EV/FCF Ratio | 15.83 | 11.03 | 23.53 | 5.80 | 7.27 | 17.73 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.07 |
Debt / EBITDA Ratio | 0.11 | 0.12 | 0.21 | 0.24 | 0.23 | 0.35 |
Debt / FCF Ratio | 0.20 | 0.17 | 0.84 | 0.40 | 0.38 | 0.72 |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.26 | -0.31 | -0.53 | -0.44 |
Net Debt / EBITDA Ratio | -0.48 | -0.49 | -1.74 | -2.07 | -2.58 | -2.42 |
Net Debt / FCF Ratio | -0.89 | -0.70 | -7.05 | -3.44 | -4.23 | -4.91 |
Asset Turnover | 0.36 | 0.34 | 0.32 | 0.27 | 0.30 | 0.43 |
Inventory Turnover | 1.53 | 1.23 | 1.31 | 1.18 | 1.40 | 2.72 |
Quick Ratio | 5.23 | 6.02 | 8.44 | 7.74 | 7.48 | 6.51 |
Current Ratio | 6.52 | 7.80 | 10.06 | 9.35 | 8.49 | 6.91 |
Return on Equity (ROE) | 13.86% | 16.72% | 12.06% | 10.14% | 14.18% | 12.58% |
Return on Assets (ROA) | 8.34% | 8.63% | 6.61% | 5.27% | 8.29% | 7.12% |
Return on Invested Capital (ROIC) | 14.26% | 19.38% | 13.58% | 14.10% | 24.60% | 22.37% |
Return on Capital Employed (ROCE) | 14.10% | 14.10% | 10.90% | 9.00% | 14.00% | 12.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.27% | 9.98% | 10.24% | 9.74% | 9.83% | 5.83% |
FCF Yield | 5.98% | 7.65% | 3.25% | 8.69% | 9.05% | 4.49% |
Dividend Yield | 4.30% | - | 6.63% | 6.02% | 5.66% | 2.15% |
Payout Ratio | 58.74% | 42.20% | 49.81% | 61.87% | - | - |
Total Shareholder Return | 4.30% | - | 6.63% | 6.02% | 5.66% | 2.15% |